Heart, Lung and Circulation最新文献

筛选
英文 中文
Short- and Long-Term Outcomes of Obstructive and Non-Obstructive Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis 梗阻性和非梗阻性肥厚性心肌病的短期和长期结局:系统回顾和荟萃分析。
IF 2.2 4区 医学
Heart, Lung and Circulation Pub Date : 2025-09-01 DOI: 10.1016/j.hlc.2025.03.011
Hui Zhen Lo BMedSci, MD , Chen Ee Low MBBS , Chun En Yau MBBS , Yao Hao Teo MBBS , Yao Neng Teo MBBS , Tony YW. Li MBBS , Nicholas L. Syn MBBS , Ping Chai MBBS , Weiqin Lin MBBS , Tiong-Cheng Yeo MBBS , William K.F. Kong MBChB , Raymond C.C. Wong MBBS , Ching-Hui Sia MBBS
{"title":"Short- and Long-Term Outcomes of Obstructive and Non-Obstructive Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis","authors":"Hui Zhen Lo BMedSci, MD ,&nbsp;Chen Ee Low MBBS ,&nbsp;Chun En Yau MBBS ,&nbsp;Yao Hao Teo MBBS ,&nbsp;Yao Neng Teo MBBS ,&nbsp;Tony YW. Li MBBS ,&nbsp;Nicholas L. Syn MBBS ,&nbsp;Ping Chai MBBS ,&nbsp;Weiqin Lin MBBS ,&nbsp;Tiong-Cheng Yeo MBBS ,&nbsp;William K.F. Kong MBChB ,&nbsp;Raymond C.C. Wong MBBS ,&nbsp;Ching-Hui Sia MBBS","doi":"10.1016/j.hlc.2025.03.011","DOIUrl":"10.1016/j.hlc.2025.03.011","url":null,"abstract":"<div><h3>Background</h3><div>Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac condition, but the risk factors and outcomes of patients with obstructive (HOCM) and non-obstructive hypertrophic cardiomyopathy (NOCM) remain unclear. This systematic review and meta-analysis was conducted to investigate the risk ratio (RR), incidence, and risk factors of all-cause and HCM-specific mortality.</div></div><div><h3>Methods</h3><div>This PRISMA-adherent systematic review involved a systematic search of PubMed, SCOPUS, and Embase for studies published from 1 January 2001 to 31 August 2023 that reported outcomes of patients with HOCM and NOCM. Random effects meta-analyses and meta-regressions were used for primary analysis.</div></div><div><h3>Results</h3><div>Sixty-one observational studies with 52,020 participants were included. All-cause, HCM-related, and heart failure-related mortality had no difference in HOCM vs NOCM patients (RR 0.85, 95% CI 0.58–1.25), (RR 0.95, 95% CI 0.68–1.32), and (RR 0.95, 95% CI 0.58–1.58), respectively. Sudden cardiac death (SCD) was significantly higher in HOCM vs NOCM patients (RR 1.69, 95% CI 1.19–2.42). Incidence of all-cause mortality (NOCM 95.47, 95% CI 63.96–140.18 vs HOCM 65.75, 95% CI 48.04–89.37) per 1,000 observations, HCM-related mortality (NOCM 59.72, 95% CI 41.91–84.42 vs HOCM 55.51, 95% CI 39.42–77.64), and SCD (NOCM 32.17, 95% CI 22.42–45.96 vs HOCM: 25.39 95% CI 15.24–42.01) were higher in NOCM patients, while heart failure-related mortality (HOCM 55.51, 95% CI 39.42–77.64 vs NOCM 30.04, 95% CI 14.78–60.11) was higher in HOCM patients.</div></div><div><h3>Conclusions</h3><div>The RR of SCD was significantly higher in HOCM vs NOCM patients. All-cause mortality, HCM-related mortality, and SCD were of higher incidence in NOCM patients. Only heart failure-related mortality was higher in HOCM patients.</div></div>","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":"34 9","pages":"Pages e104-e124"},"PeriodicalIF":2.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144698421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fluorodeoxyglucose Positron Emission Tomography Detects Persistent Arterial Inflammation After Symptomatic COVID-19 氟脱氧葡萄糖正电子发射断层扫描检测症状性COVID-19后持续动脉炎症。
IF 2.2 4区 医学
Heart, Lung and Circulation Pub Date : 2025-09-01 DOI: 10.1016/j.hlc.2025.03.005
Heidi Espedal PhD , Shipra Verma MD , Ambuj Roy MD , Nick S.R. Lan MBBS, MClinRes, MSc , Sheeraz Mohd PhD , Benjamin Bartlett PhD , Kamar Ali MSc , Natalie C. Ward PhD , Martin A. Ebert PhD , Dick C. Chan MD, PhD , Gerald F. Watts MD, PhD , Girish Dwivedi MD, PhD , Roslyn J. Francis MD, PhD
{"title":"Fluorodeoxyglucose Positron Emission Tomography Detects Persistent Arterial Inflammation After Symptomatic COVID-19","authors":"Heidi Espedal PhD ,&nbsp;Shipra Verma MD ,&nbsp;Ambuj Roy MD ,&nbsp;Nick S.R. Lan MBBS, MClinRes, MSc ,&nbsp;Sheeraz Mohd PhD ,&nbsp;Benjamin Bartlett PhD ,&nbsp;Kamar Ali MSc ,&nbsp;Natalie C. Ward PhD ,&nbsp;Martin A. Ebert PhD ,&nbsp;Dick C. Chan MD, PhD ,&nbsp;Gerald F. Watts MD, PhD ,&nbsp;Girish Dwivedi MD, PhD ,&nbsp;Roslyn J. Francis MD, PhD","doi":"10.1016/j.hlc.2025.03.005","DOIUrl":"10.1016/j.hlc.2025.03.005","url":null,"abstract":"<div><h3>Background</h3><div>There is limited knowledge of persisting vascular and systemic inflammation in adults recovered from COVID-19. This study aimed to assess whether inflammation from symptomatic mild-to-moderate COVID-19 persists beyond the apparent clinical resolution of disease using fluorodeoxyglucose positron emission tomography (FDG-PET).</div></div><div><h3>Method</h3><div>This observational single-centre cohort study invited adults (aged &gt;40 years) who had clinically recovered from mild-to-moderate COVID-19. Whole-body FDG-PET imaging and C-reactive protein test were performed on the same day after a minimum of 30 days after COVID-19 diagnosis. COVID-19–naive adults at high-risk for cardiovascular disease (CVD) were included for comparison (n=8); thoracic FDG-PET imaging was performed for these participants.</div></div><div><h3>Results</h3><div>FDG-PET imaging was performed after a median of 97 days (interquartile range [IQR] 75–113 days) after COVID-19 diagnosis. Participants who recovered from COVID-19 showed an increased arterial inflammation (median standard uptake value [SUV]<sub>max</sub> 3.1; IQR 2.7–3.3) compared with the high-risk participants with CVD (median SUV<sub>max</sub> 2.5; IQR 2.2–2.8; p&lt;0.001). There was a moderate positive correlation between the total thoracic SUV<sub>max</sub> and the bone marrow SUV<sub>mean</sub> (Spearman r=0.58; p&lt;0.001) and the spleen mean SUV<sub>max</sub> (Spearman r=0.62, p&lt;0.001) for participants who recovered from COVID-19.</div></div><div><h3>Conclusions</h3><div>Ongoing arterial inflammation is detected by FDG-PET imaging after mild-to-moderate COVID-19. Larger prospective studies are needed to assess the implications on CVD risk.</div></div>","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":"34 9","pages":"Pages 969-976"},"PeriodicalIF":2.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144505485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rural and Remote Acute STEMI Diagnosis and Management: Current Status and Future Directions. 农村和偏远地区急性STEMI的诊断和管理:现状和未来方向。
IF 2.2 4区 医学
Heart, Lung and Circulation Pub Date : 2025-09-01 DOI: 10.1016/j.hlc.2025.06.1035
Ryan Gadeley, Ruth Arnold, David Amos, Stuart Moss, Alex Elder, Sameer Karve, Mark Adams, David Brieger, Harry C Lowe
{"title":"Rural and Remote Acute STEMI Diagnosis and Management: Current Status and Future Directions.","authors":"Ryan Gadeley, Ruth Arnold, David Amos, Stuart Moss, Alex Elder, Sameer Karve, Mark Adams, David Brieger, Harry C Lowe","doi":"10.1016/j.hlc.2025.06.1035","DOIUrl":"10.1016/j.hlc.2025.06.1035","url":null,"abstract":"<p><p>Current European, American and Australasian guidelines recommend revascularisation for acute ST elevation myocardial infarction (STEMI) by immediate or \"primary\" percutaneous coronary intervention (pPCI), or if pPCI cannot be performed within 120 minutes, by thrombolysis followed by rescue PCI. This latter approach, despite its limitations, remains a cornerstone of STEMI care in rural and remote settings, where pPCI is not immediately available, and where one-third of the Australian population live. This review evaluates the current status of thrombolysis and rescue PCI in rural and remote settings, examines the multiple changes that have occurred since its inception, and highlights persisting gaps in knowledge, to provide an up-to-date evaluation of this field, and an outlook for future directions, in this area of ongoing change.</p>","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144952038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Symptomatic Neonates With Tetralogy of Fallot: Shunt or Primary Repair? 有症状的新生儿法洛四联症:分流还是初级修复?
IF 2.2 4区 医学
Heart, Lung and Circulation Pub Date : 2025-09-01 DOI: 10.1016/j.hlc.2025.01.009
Xin Tao Ye MD , Soichiro Henmi MD, PhD , Edward Buratto MBBS, PhD , Mitchell C. Haverty MS , Can Yerebakan MD , Tyson Fricke MBBS, PhD , Christian P. Brizard MD, MS , Yves d’Udekem MD, PhD , Igor E. Konstantinov MD, PhD
{"title":"Symptomatic Neonates With Tetralogy of Fallot: Shunt or Primary Repair?","authors":"Xin Tao Ye MD ,&nbsp;Soichiro Henmi MD, PhD ,&nbsp;Edward Buratto MBBS, PhD ,&nbsp;Mitchell C. Haverty MS ,&nbsp;Can Yerebakan MD ,&nbsp;Tyson Fricke MBBS, PhD ,&nbsp;Christian P. Brizard MD, MS ,&nbsp;Yves d’Udekem MD, PhD ,&nbsp;Igor E. Konstantinov MD, PhD","doi":"10.1016/j.hlc.2025.01.009","DOIUrl":"10.1016/j.hlc.2025.01.009","url":null,"abstract":"<div><h3>Background</h3><div>The optimal management strategy for symptomatic neonates with tetralogy of Fallot is unclear. We compared the outcomes of staged repair (SR) (shunt palliation followed by complete repair) and primary repair (PR) in two institutions that have each exclusively adopted one of these strategies.</div></div><div><h3>Method</h3><div>We retrospectively compared 65 symptomatic neonates who underwent shunt palliation between 1993 and 2021 at the Royal Children’s Hospital, Melbourne, Australia with 38 symptomatic neonates who underwent PR between 2005 and 2018 at the Children’s National Hospital, Washington, USA. Median follow-up duration was 8.0 (interquartile range 2.9–13.5) years.</div></div><div><h3>Results</h3><div>After the initial procedure, hospital mortality (shunt 4.6% vs PR 7.9%; p=0.50) and 5-year survival (shunt 94%; 95% confidence interval [CI] 84%–98% vs PR 89%; 95% CI 72%–96%; p=0.21) were not significantly different. The SR group had shorter durations of cardiopulmonary bypass and intensive care admission during the neonatal period, but a higher burden of unplanned re-interventions before discharge. Five-year freedom from re-interventions was not significantly different (shunt 63%; 95% CI 49%–74% vs PR 49%; 95% CI 29%–66%; p=0.13). Postoperative morbidity, mortality, and re-interventions were not significantly different among 13 propensity score–matched pairs balanced for operative weight. For neonates weighing &lt;3 kg, PR was associated with significantly more early re-interventions.</div></div><div><h3>Conclusions</h3><div>In symptomatic neonates with tetralogy of Fallot operated at two institutions with distinct treatment protocols, no statistically significant difference in medium-term survival and re-intervention was observed between the two strategies. SR was associated with lower neonatal morbidity but more unplanned re-interventions before discharge. PR in neonates weighing &lt;3 kg may result in more early re-interventions.</div></div>","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":"34 9","pages":"Pages 935-950"},"PeriodicalIF":2.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144325518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Can Australia Tackle its Failure in Research Translation to Reduce Cardiovascular Disease, Improve Equity and Deliver Better Health and Economic Outcomes? 澳大利亚能否解决其在研究转化方面的失败,以减少心血管疾病,提高公平性,并提供更好的健康和经济成果?
IF 2.2 4区 医学
Heart, Lung and Circulation Pub Date : 2025-09-01 DOI: 10.1016/j.hlc.2025.04.095
Clara Chow AM MBBS, PhD , Jason Kovacic MBBS, PhD , Bruce Neal MB ChB, PhD , Geoffrey Donnan AO MBBS, PhD , Alex Brown MBBS, PhD , Louise Maple-Brown PhD , Karen Carey BA , Richard Taggart MBA , Pamu Kularathna PhD , Sally McNeill MPH , Stephen Nicholls MBBS, PhD
{"title":"Can Australia Tackle its Failure in Research Translation to Reduce Cardiovascular Disease, Improve Equity and Deliver Better Health and Economic Outcomes?","authors":"Clara Chow AM MBBS, PhD ,&nbsp;Jason Kovacic MBBS, PhD ,&nbsp;Bruce Neal MB ChB, PhD ,&nbsp;Geoffrey Donnan AO MBBS, PhD ,&nbsp;Alex Brown MBBS, PhD ,&nbsp;Louise Maple-Brown PhD ,&nbsp;Karen Carey BA ,&nbsp;Richard Taggart MBA ,&nbsp;Pamu Kularathna PhD ,&nbsp;Sally McNeill MPH ,&nbsp;Stephen Nicholls MBBS, PhD","doi":"10.1016/j.hlc.2025.04.095","DOIUrl":"10.1016/j.hlc.2025.04.095","url":null,"abstract":"","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":"34 9","pages":"Pages 877-882"},"PeriodicalIF":2.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144717848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Shunt or Primary Repair in Symptomatic Neonates With Tetralogy of Fallot: The Time has Come for a Randomised Trial to Settle the Debate 有症状的法洛四联症新生儿的分流或初级修复:是时候进行随机试验来解决这个争论了
IF 2.2 4区 医学
Heart, Lung and Circulation Pub Date : 2025-09-01 DOI: 10.1016/j.hlc.2025.08.007
William Foot MBBS, Nelson Alphonso FRACS, Prem Venugopal FRACS
{"title":"Shunt or Primary Repair in Symptomatic Neonates With Tetralogy of Fallot: The Time has Come for a Randomised Trial to Settle the Debate","authors":"William Foot MBBS,&nbsp;Nelson Alphonso FRACS,&nbsp;Prem Venugopal FRACS","doi":"10.1016/j.hlc.2025.08.007","DOIUrl":"10.1016/j.hlc.2025.08.007","url":null,"abstract":"","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":"34 9","pages":"Pages 873-874"},"PeriodicalIF":2.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145003648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rapid Access, Real Impact: Reimagining Chest Pain Clinics for the Australian Healthcare System 快速访问,真正的影响:重新构想胸痛诊所为澳大利亚医疗保健系统
IF 2.2 4区 医学
Heart, Lung and Circulation Pub Date : 2025-09-01 DOI: 10.1016/j.hlc.2025.08.005
Travis Chong MD, MMed , Nick S.R. Lan MBBS, MClinRes , Girish Dwivedi MD, PhD
{"title":"Rapid Access, Real Impact: Reimagining Chest Pain Clinics for the Australian Healthcare System","authors":"Travis Chong MD, MMed ,&nbsp;Nick S.R. Lan MBBS, MClinRes ,&nbsp;Girish Dwivedi MD, PhD","doi":"10.1016/j.hlc.2025.08.005","DOIUrl":"10.1016/j.hlc.2025.08.005","url":null,"abstract":"","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":"34 9","pages":"Pages 869-872"},"PeriodicalIF":2.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145003647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health for Every Heart – the Heart Foundation’s 25-year vision for heart health in Australia 每个心脏的健康-心脏基金会在澳大利亚心脏健康的25年愿景
IF 2.2 4区 医学
Heart, Lung and Circulation Pub Date : 2025-09-01 DOI: 10.1016/j.hlc.2025.08.004
{"title":"Health for Every Heart – the Heart Foundation’s 25-year vision for heart health in Australia","authors":"","doi":"10.1016/j.hlc.2025.08.004","DOIUrl":"10.1016/j.hlc.2025.08.004","url":null,"abstract":"","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":"34 9","pages":"Page 984"},"PeriodicalIF":2.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145005268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Proteomic Effects of Colchicine on Human Macrophages Loaded With Oxidised Low-Density Lipoprotein Cholesterol 秋水仙碱对装载氧化低密度脂蛋白胆固醇的人巨噬细胞的蛋白质组学影响。
IF 2.2 4区 医学
Heart, Lung and Circulation Pub Date : 2025-09-01 DOI: 10.1016/j.hlc.2025.04.071
Sushma R. Rao PhD , Thalia Salagaras BSc , Yung-Chih Chen PhD , Christina A. Bursill PhD , Karlheinz Peter MD, PhD , Marten F. Snel PhD , Peter J. Psaltis MBBS, PhD
{"title":"Proteomic Effects of Colchicine on Human Macrophages Loaded With Oxidised Low-Density Lipoprotein Cholesterol","authors":"Sushma R. Rao PhD ,&nbsp;Thalia Salagaras BSc ,&nbsp;Yung-Chih Chen PhD ,&nbsp;Christina A. Bursill PhD ,&nbsp;Karlheinz Peter MD, PhD ,&nbsp;Marten F. Snel PhD ,&nbsp;Peter J. Psaltis MBBS, PhD","doi":"10.1016/j.hlc.2025.04.071","DOIUrl":"10.1016/j.hlc.2025.04.071","url":null,"abstract":"","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":"34 9","pages":"Pages 980-983"},"PeriodicalIF":2.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144859127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early and Midterm Outcomes of INSPIRIS RESILIA Versus AVALUS: A Propensity Score Matching Analysis 与阿瓦卢斯相比,抗压性脑出血的早期和中期结果:倾向评分匹配分析。
IF 2.2 4区 医学
Heart, Lung and Circulation Pub Date : 2025-09-01 DOI: 10.1016/j.hlc.2025.02.110
Takuya Narita MD, PhD , Taisuke Nakayama MD, PhD , Shuhei Nishijima MD , Yoshitsugu Nakamura MD, PhD
{"title":"Early and Midterm Outcomes of INSPIRIS RESILIA Versus AVALUS: A Propensity Score Matching Analysis","authors":"Takuya Narita MD, PhD ,&nbsp;Taisuke Nakayama MD, PhD ,&nbsp;Shuhei Nishijima MD ,&nbsp;Yoshitsugu Nakamura MD, PhD","doi":"10.1016/j.hlc.2025.02.110","DOIUrl":"10.1016/j.hlc.2025.02.110","url":null,"abstract":"<div><h3>Objectives</h3><div>To compare the early and midterm clinical outcomes of aortic valve replacement (AVR) using the INSPIRIS RESILIA bioprosthesis (IR-B) with AVR using the AVALUS bioprosthesis (AV-B).</div></div><div><h3>Methods</h3><div>This single-centre retrospective study analysed the perioperative clinical outcomes of 256 consecutive patients who underwent AVR with either IR-B (n=156) or AV-B (n=100) at this institution between 1 August 2018 and 30 June 2023. After propensity score matching, freedom from death, freedom from major adverse cardiovascular events (MACE), and echocardiographic data were compared between the two groups during the follow-up period.</div></div><div><h3>Results</h3><div><span><span>Propensity score matching resulted in the addition of 79 patients to each group. The 1-year survival rates in the propensity score-matched cohort were 93.8% and 94.5% in the IR-B and AV-B groups, respectively, while the 3-year survival rates remained unchanged, with no statistically significant differences between groups (p=0.88). At 3 years postoperatively, freedom from MACE was 93.2% and 92.8% in the IR-B and the AV-B groups, respectively, which was not statistically significant (p=0.90). The mean </span>aortic pressure gradient after AVR remained stable in both the IR-B and AV-B groups (IR-B group, 10.7–11.3 mmHg vs AV-B group, 11.5–12.1 mmHg), and there was no significant difference observed between the two groups during the follow-up period. The absolute change from the baseline left ventricular mass index in both the IR-B and AV-B groups decreased in each group over time (IR-B group, −20.8 to −38.6 g/m</span><sup>2</sup> vs AV-B group, −16.6 to −35.5 g/m<sup>2</sup>). However, these changes were statistically insignificant between the two groups over the 3-year follow-up.</div></div><div><h3>Conclusion</h3><div>The early and midterm clinical outcomes were comparable between the IR-B and AV-B groups.</div></div>","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":"34 9","pages":"Pages 908-917"},"PeriodicalIF":2.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144564673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信